CFDE Data Portal | Search PLCH2

	Label	Description
	PLCH2 Gene (Entity type)	ENSG00000149527 - phospholipase C eta 2
	PLCH2 associations Collection (Entity type)	Associations for PLCH2_associations
	PLCH2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE239844 crizotinib 6 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE193351 ruxolitinib 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 4 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 8 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE158834 12 V 6 PALMITIC ACID HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	PLCH2 HUMAN Protein (Entity type)	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2
	PLCH2 MOUSE Protein (Entity type)	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2

PLCH2

ENSG00000149527 - phospholipase C eta 2

PLCH2 associations

Associations for PLCH2_associations

PLCH2 associations.tsv

A file from IDG as part of the Harmonizome project

GSE239844 crizotinib 6 v 9 human up

A Gene Set from LINCS

GSE193351 ruxolitinib 1 v 2 human dn

A Gene Set from LINCS

GSE48812 sulforaphane 4 v 10 human dn

A Gene Set from LINCS

GSE48812 sulforaphane 8 v 1 human dn

A Gene Set from LINCS

GSE158834 12 V 6 PALMITIC ACID HUMAN UP

A Gene Set from LINCS

PLCH2 HUMAN

1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2

PLCH2 MOUSE

1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.